Market News

Boston Scientific to Acquire APEN For $10 Per Share

Boston Scientific Corp. (NYSE: BSX), the medical solutions company announced on Monday that it will acquire Apollo Endosurgery (APEN) for a cash price of $10 per share, implying an enterprise value of around $615 million.

Shares of APEN surged more than 60% in pre-market trading on Monday following the news. APEN’s product portfolio includes devices used during endoluminal surgery (ELS) procedures to close gastrointestinal defects and manage gastrointestinal complications.

BSX expects to close the acquisition in the first half of next year.

BSX scores a Strong Buy from Wall Street analysts with a unanimous 13 Buys.

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More